Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
New Pediatric Labeling Information Database - Detail
FDA Home
Pediatrics
New Pediatric Labeling Information Database
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Pediatric Labeling Date:
02/25/2011
Trade Name:
Intuniv
Generic Name or Proper Name (*):
guanfacine
Indications Studied:
Adjunctive treatment with long-acting oral psychostimulants for the treatment of ADHD
Label Changes Summary:
Approved for use as adjunctive therapy with stimulants for the treatment of ADHD in pediatric patients 6 years and olderInformation on adverse reactions and clinical trialNew indicatio
Product Labeling:
Labeling
PREA(P):
P
Sponsor:
Shire
NNPS:
FALSE'
Therapeutic Category:
Non-stimulant ADHD treatment
-
-